
Ian D. Dang
Examiner (ID: 7410)
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647 |
| Total Applications | 358 |
| Issued Applications | 151 |
| Pending Applications | 21 |
| Abandoned Applications | 186 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6449674
[patent_doc_number] => 20100145007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'CHIMERIC PEPTIDE ANTAGONIST FOR GPCR135 OR GPCR142'
[patent_app_type] => utility
[patent_app_number] => 12/449137
[patent_app_country] => US
[patent_app_date] => 2008-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6792
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20100145007.pdf
[firstpage_image] =>[orig_patent_app_number] => 12449137
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/449137 | Chimeric peptide antagonist for GPCR135 or GPCR142 | Jan 22, 2008 | Issued |
Array
(
[id] => 6231399
[patent_doc_number] => 20100184661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'CONJUGATE COMPRISING ANGIOSTATION OR ITS FRAGMENT, THE METHOD FOR PRODUCING THE CONJUGATE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/522661
[patent_app_country] => US
[patent_app_date] => 2008-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9966
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184661.pdf
[firstpage_image] =>[orig_patent_app_number] => 12522661
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/522661 | CONJUGATE COMPRISING ANGIOSTATION OR ITS FRAGMENT, THE METHOD FOR PRODUCING THE CONJUGATE AND USE THEREOF | Jan 9, 2008 | Abandoned |
Array
(
[id] => 7680709
[patent_doc_number] => 20100105877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'AN INSULINOTROPIC COMPLEX USING AN IMMUNOGLOBULIN FRAGMENT'
[patent_app_type] => utility
[patent_app_number] => 12/523050
[patent_app_country] => US
[patent_app_date] => 2008-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9955
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105877.pdf
[firstpage_image] =>[orig_patent_app_number] => 12523050
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/523050 | Insulinotropic complex using an immunoglobulin fragment | Jan 3, 2008 | Issued |
Array
(
[id] => 5435535
[patent_doc_number] => 20090170122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'Human intestinal NPT2B'
[patent_app_type] => utility
[patent_app_number] => 12/002624
[patent_app_country] => US
[patent_app_date] => 2007-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12119
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170122.pdf
[firstpage_image] =>[orig_patent_app_number] => 12002624
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/002624 | Method for screening human intestinal Npt2B modulatory agents | Dec 17, 2007 | Issued |
Array
(
[id] => 4727968
[patent_doc_number] => 20080207512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Methods for Treating Obesity and Obesity Related and Disorders'
[patent_app_type] => utility
[patent_app_number] => 11/940317
[patent_app_country] => US
[patent_app_date] => 2007-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 38446
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 68
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207512.pdf
[firstpage_image] =>[orig_patent_app_number] => 11940317
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/940317 | Methods of treating obesity with two different anti-obesity agents | Nov 13, 2007 | Issued |
Array
(
[id] => 4845487
[patent_doc_number] => 20080181895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'SP16 protein'
[patent_app_type] => utility
[patent_app_number] => 11/979577
[patent_app_country] => US
[patent_app_date] => 2007-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21637
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20080181895.pdf
[firstpage_image] =>[orig_patent_app_number] => 11979577
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/979577 | SP16 protein | Nov 5, 2007 | Abandoned |
Array
(
[id] => 5485970
[patent_doc_number] => 20090275735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'MONOCLONAL ANTIBODIES TO HUMAN CTLA-8 (IL-17A)'
[patent_app_type] => utility
[patent_app_number] => 11/930368
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17948
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275735.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930368
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930368 | Monoclonal antibodies to human CTLA-8 (IL-17A) | Oct 30, 2007 | Issued |
Array
(
[id] => 4965752
[patent_doc_number] => 20080108572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Methods and compositions for control of fetal growth via modulation of relaxin'
[patent_app_type] => utility
[patent_app_number] => 11/981338
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 32430
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108572.pdf
[firstpage_image] =>[orig_patent_app_number] => 11981338
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/981338 | Methods and compositions for control of fetal growth via modulation of relaxin | Oct 30, 2007 | Abandoned |
Array
(
[id] => 4903997
[patent_doc_number] => 20080113410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Method for Rational Pegylation of Proteins'
[patent_app_type] => utility
[patent_app_number] => 11/930051
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15429
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113410.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930051
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930051 | Method for Rational Pegylation of Proteins | Oct 29, 2007 | Abandoned |
Array
(
[id] => 33392
[patent_doc_number] => 07786077
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Insulins combinations'
[patent_app_type] => utility
[patent_app_number] => 11/927172
[patent_app_country] => US
[patent_app_date] => 2007-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14655
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/786/07786077.pdf
[firstpage_image] =>[orig_patent_app_number] => 11927172
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/927172 | Insulins combinations | Oct 28, 2007 | Issued |
Array
(
[id] => 5580930
[patent_doc_number] => 20090176276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide'
[patent_app_type] => utility
[patent_app_number] => 11/927628
[patent_app_country] => US
[patent_app_date] => 2007-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 12485
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176276.pdf
[firstpage_image] =>[orig_patent_app_number] => 11927628
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/927628 | Methods of treating using hormone-albumin fusion proteins | Oct 28, 2007 | Issued |
Array
(
[id] => 5585004
[patent_doc_number] => 20090104206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Bone microenvironment modulated migraine treatments'
[patent_app_type] => utility
[patent_app_number] => 11/975465
[patent_app_country] => US
[patent_app_date] => 2007-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14881
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104206.pdf
[firstpage_image] =>[orig_patent_app_number] => 11975465
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/975465 | Bone microenvironment modulated migraine treatments | Oct 18, 2007 | Abandoned |
Array
(
[id] => 6600845
[patent_doc_number] => 20100098689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => '4-1 bb ligand in inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 12/311170
[patent_app_country] => US
[patent_app_date] => 2007-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 22565
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20100098689.pdf
[firstpage_image] =>[orig_patent_app_number] => 12311170
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/311170 | 4-1 bb ligand in inflammatory diseases | Oct 15, 2007 | Abandoned |
Array
(
[id] => 6316953
[patent_doc_number] => 20100112566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'VIPR1S as Modifiers of the E2F/RB Pathway and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 12/442372
[patent_app_country] => US
[patent_app_date] => 2007-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16097
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20100112566.pdf
[firstpage_image] =>[orig_patent_app_number] => 12442372
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/442372 | VIPR1S as Modifiers of the E2F/RB Pathway and Methods of Use | Sep 23, 2007 | Abandoned |
Array
(
[id] => 6430599
[patent_doc_number] => 20100143330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'METHODS OF TREATING DISORDERS ASSOCIATED WITH FAT STORAGE'
[patent_app_type] => utility
[patent_app_number] => 12/445928
[patent_app_country] => US
[patent_app_date] => 2007-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15539
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143330.pdf
[firstpage_image] =>[orig_patent_app_number] => 12445928
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/445928 | METHODS OF TREATING DISORDERS ASSOCIATED WITH FAT STORAGE | Sep 23, 2007 | Abandoned |
Array
(
[id] => 5385776
[patent_doc_number] => 20090227021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'PURIFIED MAMMALIAN CTLA-8 ANTIGENS AND RELATED REAGENTS'
[patent_app_type] => utility
[patent_app_number] => 11/848672
[patent_app_country] => US
[patent_app_date] => 2007-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17888
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227021.pdf
[firstpage_image] =>[orig_patent_app_number] => 11848672
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/848672 | PURIFIED MAMMALIAN CTLA-8 ANTIGENS AND RELATED REAGENTS | Aug 30, 2007 | Abandoned |
Array
(
[id] => 6306522
[patent_doc_number] => 20100069321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Biological Materials and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/439423
[patent_app_country] => US
[patent_app_date] => 2007-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 13467
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20100069321.pdf
[firstpage_image] =>[orig_patent_app_number] => 12439423
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/439423 | Biological Materials and Uses Thereof | Aug 30, 2007 | Abandoned |
Array
(
[id] => 4845493
[patent_doc_number] => 20080181901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Protein modulator of the plasma membrane Na,K-ATPase'
[patent_app_type] => utility
[patent_app_number] => 11/892666
[patent_app_country] => US
[patent_app_date] => 2007-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11001
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20080181901.pdf
[firstpage_image] =>[orig_patent_app_number] => 11892666
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/892666 | Nucleic acids encoding proteins for modulating Na,K-ATPase | Aug 23, 2007 | Issued |
| 61/190035 | Amino acid substituted molecules | Aug 19, 2007 | Pending |
Array
(
[id] => 4441443
[patent_doc_number] => 07927852
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-19
[patent_title] => 'Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/882750
[patent_app_country] => US
[patent_app_date] => 2007-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7168
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/927/07927852.pdf
[firstpage_image] =>[orig_patent_app_number] => 11882750
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/882750 | Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates | Aug 2, 2007 | Issued |